Lenz Therapeutics Announces FDA Approval of Vizz for the Treatment of Presbyopia
-
July 8, 2025
-
2 min
July 8, 2025
Vizz (aceclidine ophthalmic solution) 1.44%, from Lenz Therapeutics, offers spectacle-free vision and the opportunity to secure patient loyalty.
January 1, 2026
Atia Vision reports positive 36-month data for its shape-changing IOL at ASCRS 2026
April 28, 2026